Comparison Chart Actinium Pharmaceuticals, Inc.
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 1.140 USD | -3.39% |
|
-2.56% | -16.18% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -3.39% | -2.56% | -16.18% | -29.63% | -86.97% | 37.1M |  | | |
- Stock Market
- Stocks
- ATNM Stock
- Charts Actinium Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
